Delivery Order SPE2DR25D7059-SPE2DR26F7MTC
- Not listed
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...
- This delivery order, awarded December 5, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract carries a ceiling value of $3,648.12 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging on November 25, 2025. This competitively awarded, firm fixed-price contract has a ceiling value of $1,597.82 with an ultimate completion date of November 26, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery...
- The Defense Logistics Agency awarded a $2,497.20 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s, with completion targeted for September 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,995.68 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The award was issued on December 3, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 units, with a contract value of $1,042.71. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. Performance will occur at AmerisourceBergen's corporate office in...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MTCDelivery Order
The Defense Logistics Agency awarded a $7,491.60 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. This is a firm fixed-price contract with performance completion targeted for December 9, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. Oseltamivir, an antiviral medication commonly used for influenza treatment and prophylaxis, represents the type of critical pharmaceutical commodity regularly procured through this strategic contract vehicle to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 12/7/25 |